YHB Investment Advisors Inc. Sells 56 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

YHB Investment Advisors Inc. decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,940 shares of the medical equipment provider’s stock after selling 56 shares during the quarter. Intuitive Surgical makes up 0.9% of YHB Investment Advisors Inc.’s investment portfolio, making the stock its 27th biggest holding. YHB Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $11,452,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at $26,000. Godsey & Gibb Inc. grew its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 1.8 %

ISRG stock opened at $573.48 on Tuesday. The firm has a 50 day moving average of $547.16 and a 200-day moving average of $505.21. The firm has a market capitalization of $204.26 billion, a P/E ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday. BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Evercore ISI boosted their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Jamie Samath sold 269 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,265 shares of company stock valued at $21,964,281. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.